Clinical Trial Investigative Site Network Market Size, Share & Trends Analysis Report By Therapeutic Areas (Oncology, CNS), By Phase (Phase I, III), By End-use (Sponsor, CRO), By Region, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Therapeutic Areas
1.1.2. Phase
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. Clinical Trial Investigative Site Network Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing partnership amongst contract research sites, thereby boosting the growth of clinical trial investigative site networks
3.3.1.2. High prevalence of diseases worldwide contributing to the demand for clinical research
3.3.1.3. Globalization of clinical trials
3.3.2. Market restraint analysis
3.3.2.1. Communication errors between sites and principal investigators
3.3.2.2. Complexities in clinical studies and research procedures
3.4. Clinical Trial Investigative Site Network Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PESTEL Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
3.5. Covid-19 Impact Analysis and Reformation Strategies
Chapter 4. Clinical Trial Investigative Site Network Market: Therapeutic Areas Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Clinical Trial Investigative Site Network Market Share, 2021 & 2030
4.2.1. Oncology
4.2.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
4.2.2. Cardiology
4.2.2.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
4.2.3. CNS
4.2.3.1. CNS market estimates and forecast 2018 to 2030 (USD Million)
4.2.4. Pain Management
4.2.4.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
4.2.5. Endocrine
4.2.5.1. Endocrine market estimates and forecast 2018 to 2030 (USD Million)
4.2.6. Others
4.2.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Clinical Trial Investigative Site Network Market: Phase Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Clinical Trial Investigative Site Network Market Share, 2021 & 2030
5.2.1. Phase I
5.2.1.1. Phase I market estimates and forecast 2018 to 2030 (USD Million)
5.2.2. Phase II
5.2.2.1. Phase II market estimates and forecast 2018 to 2030 (USD Million)
5.2.3. Phase III
5.2.3.1. Phase III market estimates and forecast 2018 to 2030 (USD Million)
5.2.4. Phase IV
5.2.4.1. Phase IV market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Clinical Trial Investigative Site Network Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Clinical Trial Investigative Site Network Market Share, 2021 & 2030
6.2.1. Sponsor
6.2.1.1. Sponsors market estimates and forecast 2018 to 2030 (USD Million)
6.2.2. CRO
6.2.2.1. CRO market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Clinical Trial Investigative Site Network Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2021 & 2030
7.2. North America
7.2.1. U.S.
7.2.1.1. U.S. Market estimates and forecast, 2018 - 2030
7.2.2. Canada
7.2.2.1. Canada Market estimates and forecast, 2018 - 2030
7.3. Europe
7.3.1. U.K.
7.3.1.1. U.K. Market estimates and forecast, 2018 - 2030
7.3.2. Germany
7.3.2.1.德国市场估计和预测,2018 - 2030
7.3.3. France
7.3.3.1. France Market estimates and forecast, 2018 - 2030
7.3.4. Italy
7.3.4.1. Italy Market estimates and forecast, 2018 - 2030
7.3.5. Spain
7.3.5.1. Spain Market estimates and forecast, 2018 - 2030
7.3.6. The Netherlands
7.3.6.1. The Netherlands Market estimates and forecast, 2018 - 2030
7.3.7. Sweden
7.3.7.1. Sweden Market estimates and forecast, 2018 - 2030
7.3.8. Switzerland
7.3.8.1. Switzerland Market estimates and forecast, 2018 - 2030
7.3.9. Russia
7.3.9.1. Russia Market estimates and forecast, 2018 - 2030
7.3.10. Belgium
7.3.10.1. Belgium Market estimates and forecast, 2018 - 2030
7.4. Asia Pacific
7.4.1. Japan
7.4.1.1. Japan Market estimates and forecast, 2018 - 2030
7.4.2. China
7.4.2.1. China Market estimates and forecast, 2018 - 2030
7.4.3. India
7.4.3.1. India Market estimates and forecast, 2018 - 2030
7.4.4. Australia
7.4.4.1. Australia Market estimates and forecast, 2018 - 2030
7.4.5. South Korea
7.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
7.4.6. Thailand
7.4.6.1. Thailand Market estimates and forecast, 2018 - 2030
7.4.7. Malaysia
7.4.7.1. Malaysia Market estimates and forecast, 2018 - 2030
7.4.8. New Zealand
7.4.8.1. New Zealand Market estimates and forecast, 2018 - 2030
7.4.9. Philippines
7.4.9.1. Philippines Market estimates and forecast, 2018 - 2030
7.4.10. Singapore
7.4.10.1. Singapore Market estimates and forecast, 2018 - 2030
7.5. Latin America
7.5.1. Brazil
7.5.1.1. Brazil Market estimates and forecast, 2018 - 2030
7.5.2. Mexico
7.5.2.1. Mexico Market estimates and forecast, 2018 - 2030
7.5.3. Argentina
7.5.3.1. Argentina Market estimates and forecast, 2018 - 2030
7.5.4. Colombia
7.5.4.1. Colombia Market estimates and forecast, 2018 - 2030
7.5.5. Chile
7.5.5.1. Chile Market estimates and forecast, 2018 - 2030
7.6. MEA
7.6.1. South Africa
7.6.1.1. South Africa Market estimates and forecast, 2018 - 2030
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
7.6.3. UAE
7.6.3.1. UAE Market estimates and forecast, 2018 - 2030
7.6.4. Israel
7.6.4.1. Israel Market estimates and forecast, 2018 - 2030
7.6.5. Egypt
7.6.5.1. Egypt Market estimates and forecast, 2018 - 2030
Chapter 8. Competitive Analysis
8.1. Recent Developments & Impact Analysis, By Key Market Participant
8.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.3. Participant Categorization
8.4.供应商的景观
8.4.1. List of Key Service Providers
8.4.2. Market Differentiators
8.5. Market share analysis
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. ICON plc
9.1.1.1. Company overview
9.1.1.2. Product benchmarking
9.1.1.3. Strategic initiatives
9.1.2. MERIDIAN CLINICAL RESEARCH
9.1.2.1. Company overview
9.1.2.2. Financial performance
9.1.2.3. Product benchmarking
9.1.2.4. Strategic initiatives
9.1.3. IQVIA Inc.
9.1.3.1. Company overview
9.1.3.2. Financial performance
9.1.3.3. Product benchmarking
9.1.3.4. Strategic initiatives
9.1.4. Clinedge
9.1.4.1. Company overview
9.1.4.2. Financial performance
9.1.4.3. Product benchmarking
9.1.4.4. Strategic initiatives
9.1.5. WCG
9.1.5.1. Company overview
9.1.5.2. Financial performance
9.1.5.3. Product benchmarking
9.1.5.4. Strategic initiatives
9.1.6. ClinChoice
9.1.6.1. Company overview
9.1.6.2. Financial performance
9.1.6.3. Product benchmarking
9.1.6.4. Strategic initiatives
9.1.7. Access Clinical Research
9.1.7.1. Company overview
9.1.7.2. Financial performance
9.1.7.3. Product benchmarking
9.1.7.4. Strategic initiatives
9.1.8. FOMAT Medical Research INC.
9.1.8.1. Company overview
9.1.8.2. Financial performance
9.1.8.3. Product benchmarking
9.1.8.4. Strategic initiatives
9.1.9. SGS SA
9.1.9.1. Company overview
9.1.9.2. Financial performance
9.1.9.3. Product benchmarking
9.1.9.4. Strategic initiatives
9.1.10. KV Clinical
9.1.10.1. Company overview
9.1.10.2. Financial performance
9.1.10.3. Product benchmarking
9.1.10.4. Strategic initiatives
9.1.11. SMO-Pharmina
9.1.11.1. Company overview
9.1.11.2. Financial performance
9.1.11.3. Product benchmarking
9.1.11.4. Strategic initiatives
9.1.12. Xylem Clinical Research
9.1.12.1. Company overview
9.1.12.2. Financial performance
9.1.12.3.产品基准测试
9.1.12.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume Price Analysis
Fig. 10 Clinical Trial Investigative Site Network market snapshot (2021)
Fig. 11 Clinical Trial Investigative Site Network market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Clinical Trial Investigative Site Network market therapeutic area outlook: Segment dashboard
Fig. 18 Clinical Trial Investigative Site Network market: therapeutic area movement analysis
Fig. 19 Oncology market, 2018 - 2030 (USD Million)
Fig. 20 Cardiology market, 2018 - 2030 (USD Million)
Fig. 21 CNS market, 2018 - 2030 (USD Million)
Fig. 22 Pain Management market, 2018 - 2030 (USD Million)
Fig. 23 Endocrine market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Clinical Trial Investigative Site Network market phase outlook: Segment dashboard
Fig. 26 Clinical Trial Investigative Site Network market phase outlook: Segment dashboard
Fig. 27 Phase I market, 2018 - 2030 (USD Million)
Fig. 28 Phase II market, 2018 - 2030 (USD Million)
Fig. 29 Phase III market, 2018 - 2030 (USD Million)
Fig. 30 Phase IV market, 2018 - 2030 (USD Million)
Fig. 31 Clinical Trial Investigative Site Network market end use outlook: Segment dashboard
Fig. 32 Clinical Trial Investigative Site Network market: End use movement analysis
Fig. 33 Spionsor market, 2018 - 2030 (USD Million)
Fig. 34 CRO market, 2018 - 2030 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2021 & 2030
Fig. 37 North America market, 2018 - 2030 (USD Million)
Fig. 38 U.S. market, 2018 - 2030 (USD Million)
Fig. 39 Canada market, 2018 - 2030 (USD Million)
Fig. 40 Europe market, 2018 - 2030 (USD Million)
Fig. 41 U.K. market, 2018 - 2030 (USD Million)
Fig. 42 Germany market, 2018 - 2030 (USD Million)
Fig. 43 France market, 2018 - 2030 (USD Million)
图44意大利市场,2018年2030 (USD Million)
Fig. 45 Spain market, 2018 - 2030 (USD Million)
Fig. 46 The Netherlands market, 2018 - 2030 (USD Million)
Fig. 47 Belgium market, 2018 - 2030 (USD Million)
Fig. 48 Sweden market, 2018 - 2030 (USD Million)
Fig. 49 Switzerland market, 2018 - 2030 (USD Million)
图49俄罗斯马克et, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 52 China market, 2018 - 2030 (USD Million)
Fig. 53 India market, 2018 - 2030 (USD Million)
Fig. 54 Japan market, 2018 - 2030 (USD Million)
Fig. 55 Australia market, 2018 - 2030 (USD Million)
Fig. 56 South Korea market, 2018 - 2030 (USD Million)
Fig. 57 Malaysia market, 2018 - 2030 (USD Million)
Fig. 58 New Zealand market, 2018 - 2030 (USD Million)
Fig. 59 Philippines market, 2018 - 2030 (USD Million)
Fig. 60 Thailand market, 2018 - 2030 (USD Million)
Fig. 61 Singapore market, 2018 - 2030 (USD Million)
Fig. 62 South Korea market, 2018 - 2030 (USD Million)
Fig. 63 Latin America market, 2018 - 2030 (USD Million)
Fig. 64 Brazil market, 2018 - 2030 (USD Million)
Fig. 65 Mexico market, 2018 - 2030 (USD Million)
Fig. 66 Argentina market, 2018 - 2030 (USD Million)
Fig. 67 Colombia market, 2018 - 2030 (USD Million)
Fig. 68 Chile market, 2018 - 2030 (USD Million)
Fig. 69 MEA market, 2018 - 2030 (USD Million)
Fig. 70 South Africa market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 72 Israel market, 2018 - 2030 (USD Million)
Fig. 73 Egypt market, 2018 - 2030 (USD Million)
Fig. 74 UAE market, 2018 - 2030 (USD Million)